找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Coronary Artery Disease: Therapeutics and Drug Discovery; Miao Wang Book 2020 Springer Nature Singapore Pte Ltd. 2020 coronary artery dise

[復(fù)制鏈接]
樓主: controllers
21#
發(fā)表于 2025-3-25 04:36:39 | 只看該作者
Malnutrition in Captive Birds of Preyure as well as those that prevent heart failure progression, in each category major clinical trials are also described. In addition, information about some of potential new drugs are also mentioned. Traditional Chinese medicine also shows its potential in treating HF, and we are still lack of medicine to treat HFpEF.
22#
發(fā)表于 2025-3-25 09:48:42 | 只看該作者
23#
發(fā)表于 2025-3-25 11:59:11 | 只看該作者
Pharmaceutical Treatment for Heart Failure,ure as well as those that prevent heart failure progression, in each category major clinical trials are also described. In addition, information about some of potential new drugs are also mentioned. Traditional Chinese medicine also shows its potential in treating HF, and we are still lack of medicine to treat HFpEF.
24#
發(fā)表于 2025-3-25 18:24:56 | 只看該作者
Book 2020e. It highlights drug pharmacology and therapeutic challenges, with a special emphasis on the underlying principles of available therapeutics and the on-going development of drugs for coronary artery disease..The book is divided into eight chapters, the first of which describes the classical mechani
25#
發(fā)表于 2025-3-25 21:55:16 | 只看該作者
26#
發(fā)表于 2025-3-26 02:00:34 | 只看該作者
A. Aeschlimann,C. Mermod,J. F. Graf need. In this chapter, we provide an overview on the pathophysiology of thrombosis, followed by introduction of each class of antithrombotic drugs including their pharmacology, clinical applications and limitations. Practical challenges and future perspectives of antithrombotic drugs are discussed in the last part of this chapter.
27#
發(fā)表于 2025-3-26 06:00:32 | 只看該作者
28#
發(fā)表于 2025-3-26 09:56:28 | 只看該作者
29#
發(fā)表于 2025-3-26 13:55:14 | 只看該作者
30#
發(fā)表于 2025-3-26 18:54:49 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-9 15:32
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
溧水县| 英德市| 集安市| 山东省| 甘谷县| 陆良县| 韶关市| 定安县| 通州区| 河津市| 阿图什市| 观塘区| 贵州省| 和平县| 中牟县| 山东省| 桃园县| 甘孜县| 上虞市| 鄂温| 阳江市| 清水河县| 子长县| 太湖县| 商都县| 石渠县| 武乡县| 无棣县| 疏附县| 杭锦旗| 二连浩特市| 东至县| 天峨县| 临汾市| 新安县| 长丰县| 周口市| 竹山县| 泰兴市| 昌乐县| 黎川县|